1. Home
  2. MIAX vs CNTA Comparison

MIAX vs CNTA Comparison

Compare MIAX & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MIAX

Miami International Holdings Inc.

HOLD

Current Price

$46.83

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

SELL

Current Price

$39.43

Market Cap

6.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MIAX
CNTA
Founded
2007
2020
Country
United States
United Kingdom
Employees
439
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
6.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MIAX
CNTA
Price
$46.83
$39.43
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$47.00
$43.17
AVG Volume (30 Days)
1.0M
3.0M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.13
EPS
N/A
N/A
Revenue
N/A
$15,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.20
$10.95
52 Week High
$51.38
$40.26

Technical Indicators

Market Signals
Indicator
MIAX
CNTA
Relative Strength Index (RSI) 67.08 73.10
Support Level $41.36 $39.16
Resistance Level $48.42 $40.26
Average True Range (ATR) 1.25 0.19
MACD 0.29 -0.48
Stochastic Oscillator 80.35 59.18

Price Performance

Historical Comparison
MIAX
CNTA

About MIAX Miami International Holdings Inc.

Miami International Holdings Inc is engaged in operating regulated financial marketplaces across multiple asset classes using proprietary technology platforms. The company operates exchange markets for options, equities, futures, and international listings through its MIAX Exchanges, MIAX Futures Exchange, and the Bermuda Stock Exchange. The company operates through four reportable segments: Options, which provides trading and market data services for listed equity and ETP options; Equities, which provides trading services for U.S. equities and ETPs; Futures, which provides futures trading and clearing services through MIAX Futures; and International, which provides listing services for capital market instruments through the Bermuda Stock Exchange and The International Stock Exchange.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: